2020
DOI: 10.1016/j.bmcl.2020.127348
|View full text |Cite
|
Sign up to set email alerts
|

In vitro and in vivo evaluation of the antimalarial MMV665831 and structural analogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(7 citation statements)
references
References 30 publications
0
7
0
Order By: Relevance
“…falciparum strains. While ester 27 was not active in vivo (mouse), compounds 28 – 30 revealed activity in mouse models of acute malaria even after oral application. , 29 and 30 are currently under preclinical evaluation and 32 is already used for the treatment of malaria patients. The structure and mode of action of 32 and chloroquine are very similar, but 32 has a longer plasma elimination half-life than chloroquine.…”
Section: Discussionmentioning
confidence: 57%
See 4 more Smart Citations
“…falciparum strains. While ester 27 was not active in vivo (mouse), compounds 28 – 30 revealed activity in mouse models of acute malaria even after oral application. , 29 and 30 are currently under preclinical evaluation and 32 is already used for the treatment of malaria patients. The structure and mode of action of 32 and chloroquine are very similar, but 32 has a longer plasma elimination half-life than chloroquine.…”
Section: Discussionmentioning
confidence: 57%
“…Some antimalarial drugs containing the 2-(aminomethyl)­phenol substructure have already been reported in the literature. Amodiaquine ( 32 ) containing this structural motif is used clinically for the therapy of malaria. , Some prototypes including amodiaquine are displayed in Figure . The compounds 27 – 30 were identified by screening of compound libraries and subsequent specific modifications.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations